Manitoba Health, Seniors and Long-Term Care (MHSLTC) has proposed amendments to the Pharmaceutical Regulation to enable pharmacist prescribing of specific dosage forms of hormonal contraception, as well as pharmacist administration of injectable contraceptives prescribed by pharmacists.
Proposed Amendments
1. Amendment to Section 110: This amendment will allow injection-authorized pharmacists to administer a drug that is prescribed for contraception.
2. Added to Section 118: A pharmacist who has completed training approved by the council may prescribe a contraceptive drug product authorized by Health Canada in the following dosage forms:
i. an oral contraceptive,
ii. a transdermal patch,
iii. a vaginal ring,
iv. a solution administered through intradermal, subcutaneous or intramuscular injection.
You can access the proposed amendments here: https://cphm.ca/pharmaceutical-regulation-amendment_consultation-document/
Background
CPhM and other system partners have been engaging with MHSLTC regarding pharmacist prescribing of hormonal contraception, which would ensure broader access to prescription birth control. The ability for pharmacists to prescribe hormonal contraception is already in place in eight provinces across Canada (BC, AB, SK, QC, NB, NS, PEI and NL).
The regulatory amendment also ensures pharmacist prescribing of contraception is done safely, ethically, and in the public interest. This includes the requirement for completion of a Council-approved training program, as well as the limitation that pharmacists only prescribe drugs Health Canada has indicated for the purpose.
Consultation Period
The CPhM Council has approved a 30-day public consultation period for these draft regulation amendments. We encourage you to review the proposed changes and provide your feedback. Comments can be submitted via email with the subject line ‘Consultation Feedback’ to feedback@cphm.ca by May 8, 2026.
Should you have any questions, please email info@cphm.ca